Lunai Bioworks Initiates $20 Million Acquisition for CNS Alzheimer's Drug Delivery Advancements Lunai Bioworks is set to acquire blood-brain barrier technology for CNS Alzheimer's therapies in a $20M deal, strengthening drug delivery efficiency.

Lunai Bioworks Initiates $20 Million Acquisition for CNS Alzheimer's Drug Delivery Advancements #United_States #Sacramento #Lunai_Bioworks #CNS_Drug_Delivery #Alzheimer's_Therapies